Search

everythinglearnresearchcommunity

for

Search:↓

A child was initially wrongly diagnosed with a fungal scalp infection but actually had a non-scarring hair loss condition called Temporal Triangular Alopecia.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Minoxidil caused a severe rash in a patient, which improved after stopping the drug.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Steroid hormones can help treat aging issues and improve health in elderly people.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Acne keloidalis nuchae is a chronic skin condition more common in African men, causing itchy or painful bumps and can lead to permanent hair loss if not treated early.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.